

Planning the routing of oncological patients with head-neck tumors at the regional level
https://doi.org/10.47470/0044-197X-2025-69-3-225-231
EDN: kgmwfv
Abstract
Introduction. The principles of diagnosis and treatment of malignant neoplasms in the Russian Federation is based on clinical recommendations validated by the state, as well as the normative principles of the management of oncological care. The planning of such care for relatively rare tumors in the territories with low population density is a special challenge.
Materials and methods. The authors analyzed the legislative requirements and proposed possible models of care manahement for patients with head-neck tumors on the example of one of the regions of the Russian Federation — Yamalo-Nenets Autonomous Okrug (YNAO), the features of which include a relatively low incidence of these neoplasms — 4.3 per 100 thousand population to the data of 2022.
Results. Taking into account the peculiarities of the medical infrastructure of the study region and the morbidity rate, the basic modeling of routing for head-neck tumors and oncological consultations by the multidisciplinary team (MDT) in a remote format, enshrined in the regulatory documents of the regional Department of Health Care, was performed. The influence of the proposed approaches on the quality of diagnostics at the level of outpatient cancer care center was studied, the modification of the basic model for patients with «head-neck» tumors was justified, and the ranking evaluation of the two presented models. The advantage of the modified scheme in nine studied parameters is shown. The differences in the evaluation are statistically significant (p = 0.005).
Research limitations. The present study is relevant for regions with an incidence rate of head-neck tumors below the national average.
Conclusion. The proposed solution can serve as a basis for managing approaches for regional medical institutions providing specialized oncological care for tumors rarely occurring in the region.
Compliance with ethical standards. The study does not require the submission of a medical ethics report or other documentation.
Contribution of the authors:
Parts S.A. — concept and design of the study, statistical analysis, writing text, illustrations, scientific editing;
Leskov S.V. — literature search and review, data analysis, structuring an article;
Kulikova E.N. — data analysis, structuring an article;
Reshetov I.V., Galkin V.N. — writing text, structuring an article;
Kuzmina E.S. — writing text, structuring an article, scientific editing.
All authors are responsible for the integrity of all parts of the manuscript and approval of the manuscript final version.
Funding. The study had no sponsorship.
Conflict of interest. The authors declare no conflict of interest.
Received: April 16, 2024 / Accepted: October 3, 2024 / Published: June 30, 2025
About the Authors
Sergey A. PartsRussian Federation
PhD (Medicine), Deputy Chief Physician for Oncology, S.S. Yudin City Clinical Hospital of the Moscow City Department of Health, 115446, Moscow, Russian Federation
e-mail: saparts@yandex.ru
Sergey V. Leskov
Russian Federation
Oncologist doctor, Head of the Interdistrict Oncology Center of the Yamalo-Nenets Autonomous Okrug, Noyabrsk Central City Hospital, Noyabrsk, 629806, Russian Federation
e-mail: leskovsv@rambler.ru
Elena N. Kulikova
Russian Federation
Oncologist doctor, Head of the Outpatient Oncology Care, Noyabrsk Central City Hospital, Noyabrsk, 629806, Russian Federation
e-mail: kulikova_elena2020@mail.ru
Igor V. Reshetov
Russian Federation
Academician RAS, DSc (Medicine), Professor, Director of the Institute of Cluster Oncology named after prof. L.L. Levshin, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, 119435, Russian Federation
e-mail: reshetoviv@mail.ru
Evgeniya S. Kuzmina
Russian Federation
PhD (Medicine), Head of the Chemotherapy Department, Moscow City Hospital named after S.S. Yudin, Moscow, 115446, Russian Federation
e-mail: kuz011@mail.ru
Vsevolod N. Galkin
Russian Federation
DSc (Medicine), Professor, chief physician, Moscow City Hospital named after S.S. Yudin, Moscow, 115446, Russian Federation
e-mail: vsgalkin@gmail.com
References
1. Vaninov A.S. Malignant neoplasms as the most priority medical and social issue of the healthcare system. Byulleten’ nauki i praktiki. 2019; 5(11): 120–30. https://doi.org/10.33619/2414-2948/48/16 https://elibrary.ru/qiqvtc (in Russian)
2. Kaprin A.D., Starinskii V.V., Shakhzadov A.O., eds. Malignant Neoplasms in Russia in 2021 (Morbidity and Mortality) [Zlokachestvennye novoobrazovaniya v Rossii v 2021 godu (zabolevaemost’ i smertnost’)]. Moscow; 2022. (in Russian)
3. Shakhzadova A.O., Starinsky V.V., Lisichnikova I.V. Cancer care to the population of Russia in 2022. Sibirskii onkologicheskii zhurnal. 2023; 22(5): 5–13. https://doi.org/10.21294/1814-4861-2023-22-5-5-13 https://elibrary.ru/peshhl (in Russian)
4. Golubev S.V., Startsev V.Yu., Samsonov Yu.V. Organization of the regional cancer service to improve the detection of malignant new formations during the COVID-19 pandemic. Issledovaniya i praktika v meditsine. 2021; 8(2): 133–40. https://doi.org/10.17709/2410-1893-2021-8-2-12 https://elibrary.ru/xzmeil (In Russian)
5. Shelyakin V.A., Linnik S.А., Tretyakov D.A., Khudyaev A.S., Shvachko S.A. Planning medical care for patients with cancer in the constituent entities of the Russian Federation. Menedzher zdravookhraneniya. 2023; (1): 60–9. https://doi.org/10.21045/1811-0185-2023-1-60-69 https://elibrary.ru/qjncbt (in Russian)
6. Naigovzina N.B., Son I.M., Korchuganova E.A., Titkova Yu.S., Tsvetkova E.A., Makarova N.C., et al. Problems of application of medical care procedures. Literature review. Sovremennye problemy zdravookhraneniya i meditsinskoi statistiki. 2022; (5): 702–24. https://doi.org/10.24412/2312-2935-2022-5-702-724 https://elibrary.ru/slytyk (in Russian)
7. Pligina E.V., Semeleva E.V. Organization of the oncological service of the Republic of Mordovia. Lechashchii vrach. 2023; 26(1): 45–8. https://doi.org/10.51793/OS.2023.26.1.008 https://elibrary.ru/kvutlo (in Russian)
8. Ogneva E.Yu., Gurov A.N., Pirogov M.V., Gameeva E.V., Aleksandrova O.Yu. Analysis of the availability and direction of improvement of medical care for patients with malignant neoplasms in the Moscow region. Issledovaniya i praktika v meditsine. 2018; 5(4): 106–17. https://doi.org/10.17709/2409-2231-2018-5-4-11 https://elibrary.ru/yqvqqp (in Russian)
9. Parts S.A., Reshetov I.V., Kuzmina E.S., Galkin V.N. Organizational models of cancer patient routing at the regional level. Consilium Medicum. 2023; 25(6): 384–7. https://doi.org/10.26442/20751753.2023.6.202322 https://elibrary.ru/mynpul (in Russian)
10. Pillay B., Wootten A.C., Crowe H., Corcoran N., Tran B., Bowden P., et al. The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: a systematic review of the literature. Cancer Treat. Rev. 2016; 42: 56–72. https://doi.org/10.1016/j.ctrv.2015.11.007
11. Houssami N., Sainsbury R. Breast cancer: multidisciplinary care and clinical outcomes. Eur. J. Cancer. 2006; 42(15): 2480–91. https://doi.org/10.1016/j.ejca.2006.05.023
12. Parts S.A., Reshetov I.V., Kuzmina E.S., Galkin V.N. Improving the efficiency of the Multidisciplinary Oncology Consultation in Moscow Outpatient Oncology Care Centers. Voprosy onkologii. 2024; 70(2): 377–83. https://doi.org/10.37469/0507-3758-2024-70-2-377-383 https://elibrary.ru/tpmnpd (in Russian)
Review
For citations:
Parts S.A., Leskov S.V., Kulikova E.N., Reshetov I.V., Kuzmina E.S., Galkin V.N. Planning the routing of oncological patients with head-neck tumors at the regional level. Health care of the Russian Federation. 2025;69(3):225-231. (In Russ.) https://doi.org/10.47470/0044-197X-2025-69-3-225-231. EDN: kgmwfv